2.10
0.05 (2.44%)
| Previous Close | 2.05 |
| Open | 2.05 |
| Volume | 458,212 |
| Avg. Volume (3M) | 531,438 |
| Market Cap | 56,135,096 |
| Price / Earnings (Forward) | 43.10 |
| Price / Sales | 1.52 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -30.75% |
| Operating Margin (TTM) | -13.36% |
| Diluted EPS (TTM) | -0.550 |
| Quarterly Revenue Growth (YOY) | 6.00% |
| Current Ratio (MRQ) | 1.41 |
| Operating Cash Flow (TTM) | -8.02 M |
| Levered Free Cash Flow (TTM) | -2.16 M |
| Return on Assets (TTM) | -18.42% |
| Return on Equity (TTM) | -2,308.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Spectral AI, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 30.56% |
| % Held by Institutions | 14.04% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Highlander Partners, L.P. | 30 Jun 2025 | 900,000 |
| University Of Texas/Texas Am Investment Management Co | 30 Jun 2025 | 210,488 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Sep 2025 | Announcement | DeepView® System highlighted at the European Burns Association Congress |
| 12 Aug 2025 | Announcement | Spectral AI Announces 2025 Second Quarter Financial Results |
| 30 Jul 2025 | Announcement | Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call |
| 29 Jul 2025 | Announcement | AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks |
| 30 Jun 2025 | Announcement | Spectral AI Announces Submission to FDA of its DeepView® System |
| 20 Jun 2025 | Announcement | AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |